Levofloxacin + Solifenacin succinate + Placebo (for Solifenacin succinate)
ApprovedUNKNOWN 0 views this week 0 watching💤 Quiet
Interest: 39/100
39
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Urinary Tract Infection
Conditions
Urinary Tract Infection
Trial Timeline
Apr 1, 2013 → Dec 1, 2014
NCT ID
NCT02094703About Levofloxacin + Solifenacin succinate + Placebo (for Solifenacin succinate)
Levofloxacin + Solifenacin succinate + Placebo (for Solifenacin succinate) is a approved stage product being developed by Astellas Pharma for Urinary Tract Infection. The current trial status is unknown. This product is registered under clinical trial identifier NCT02094703. Target conditions include Urinary Tract Infection.
What happened to similar drugs?
20 of 20 similar drugs in Urinary Tract Infection were approved
Approved (20) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
20
Activity
4
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02094703 | Approved | UNKNOWN |
Competing Products
20 competing products in Urinary Tract Infection